Keywords: Pfizer, Pristiq, Eli Lilly, Cymbalta, Private plan formulary, USA, Antidepressants

Pfizer’s Pristiq sees private plan formulary access similar to Lilly’s Cymbalta

Article | 31 August 2011

Print This

In the USA, similar percentages of private health plan lives have formulary access to Pfizer’s (NYSE: PFE) serotonin-norepinephrine ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in